Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Connolly

Showing results (321-330 of 380) with videos related to

Pageof 38
Sort By:
Journal for Immunotherapy of Cancer|December 2, 2025
Enabling access to genetically modified cell therapies through flexible approaches to manufacturing and cost recoveryMark D Stewart, Christopher R Cabanski, Jeff D Allen, et al.
Clinical Rheumatology|May 10, 2022
Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational studyRieke Alten, Xavier Mariette, René-Marc Flipo, et al.
Life Science Alliance|September 22, 2023
Themis controls T cell activation, effector functions, and metabolism of peripheral CD8<sup>+</sup> T cellsNamrata Gautam, Lukasz Wojciech, Jiawei Yap, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2026
Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritisJinqi Liu, Yicong Li, Kai Fu, et al.
Annals of Biomedical Engineering|January 16, 2015
Evaluation of Cartilage Repair by Mesenchymal Stem Cells Seeded on a PEOT/PBT Scaffold in an Osteochondral DefectV Barron, K Merghani, G Shaw, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 25, 2018
Toll-Like Receptor 9 Deficiency Breaks Tolerance to RNA-Associated Antigens and Up-Regulates Toll-Like Receptor 7 Protein in Sle1 MiceTeja Celhar, Hiroko Yasuga, Hui Yin Lee, et al.
Rheumatology and Therapy|March 3, 2023
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid ArthritisPaul Emery, Yoshiya Tanaka, Vivian P Bykerk, et al.
Life Science Alliance|March 4, 2025
Molecular analysis of acute pyelonephritis-excessive innate and attenuated adaptive immunityInes Ambite, Sing Ming Chao, Therese Rosenblad, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|December 21, 2019
Priority setting for adult malnutrition and nutritional screening in healthcare: a James Lind AllianceD J Jones, C Baldwin, S Lal, et al.
Open Forum Infectious Diseases|June 23, 2023
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of OmicronMichael G Ison, Myra Popejoy, Nikolay Evgeniev, et al.
Pageof 38

Showing results (321-330 of 380) with videos related to

Sort By:
Pageof 38
Journal for Immunotherapy of Cancer|December 2, 2025
Enabling access to genetically modified cell therapies through flexible approaches to manufacturing and cost recoveryMark D Stewart, Christopher R Cabanski, Jeff D Allen, et al.
Clinical Rheumatology|May 10, 2022
Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational studyRieke Alten, Xavier Mariette, René-Marc Flipo, et al.
Life Science Alliance|September 22, 2023
Themis controls T cell activation, effector functions, and metabolism of peripheral CD8<sup>+</sup> T cellsNamrata Gautam, Lukasz Wojciech, Jiawei Yap, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2026
Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritisJinqi Liu, Yicong Li, Kai Fu, et al.
Annals of Biomedical Engineering|January 16, 2015
Evaluation of Cartilage Repair by Mesenchymal Stem Cells Seeded on a PEOT/PBT Scaffold in an Osteochondral DefectV Barron, K Merghani, G Shaw, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 25, 2018
Toll-Like Receptor 9 Deficiency Breaks Tolerance to RNA-Associated Antigens and Up-Regulates Toll-Like Receptor 7 Protein in Sle1 MiceTeja Celhar, Hiroko Yasuga, Hui Yin Lee, et al.
Rheumatology and Therapy|March 3, 2023
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid ArthritisPaul Emery, Yoshiya Tanaka, Vivian P Bykerk, et al.
Life Science Alliance|March 4, 2025
Molecular analysis of acute pyelonephritis-excessive innate and attenuated adaptive immunityInes Ambite, Sing Ming Chao, Therese Rosenblad, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|December 21, 2019
Priority setting for adult malnutrition and nutritional screening in healthcare: a James Lind AllianceD J Jones, C Baldwin, S Lal, et al.
Open Forum Infectious Diseases|June 23, 2023
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of OmicronMichael G Ison, Myra Popejoy, Nikolay Evgeniev, et al.
Pageof 38